Back to results
US 2004/0082666 A1Published application
Inhibitor of monoamine uptake
OwnerEdward Louis Mattiuz, John-Michael Sauer +2inventors
InventorsEdward Louis Mattiuz, John-Michael Sauer, William Joe Wheeler, David Taiwai Wong
Life of this patent
Estimating the term…
Abstract
The present invention provides compounds and methods for the inhibition of monoamine uptake in mammals.
Claims6
A compound of Formula I:
- 8
- or a pharmaceutically acceptable salt thereof.
The compound R-(−)-N-methyl 3-((2-methyl-4-hydroxyphenyl)oxy)-3-phenyl-1-aminopropane hydrochloride.
A pharmaceutical formulation comprising a compound of Formula I:
- 9
- or a pharmaceutically acceptable salt thereof, in association with a pharmaceutically acceptable carrier, diluent or excipient.
A method for inhibiting the uptake of norepinephrine and serotonin in mammals comprising administering to a mammal in need of such inhibition a pharmaceutically effective amount of a compound of Formula I:
- 10
- or a pharmaceutically acceptable salt thereof.
Dependencies are inferred from the claim text.